ATGACGGATGCCGGAATTGGCATGACGGATGCCGGAATTGGCACATAACAAGTACTGCTCGGTCCTTAAGCTGTATTGCACCATATGACGG
ATGCCGGAATTGGCACATAACAAGTACTGCCTCGGTCCTTAAGCTGTATTGCACCATATGACGGATGCCGGAATTGGCACATAACAAGTAC
TGCCTCGGTCCTTAAGCTGTATTGCACCATATGACGGATGCCGGAATTGGCACATAACAACGGTCCTTAAGCTGTATTGCACCATATGACG
GATGCCGGAATTGGCACATAACAAGTACTGCCTCGGTCCTTAAGCTGTATTTCGGTCCTTAAGCTGTATTCCTTAACAACGGTCCTTAAGG
ATGACGGATGCCGGAATTGGCATGACGGATGCCGGAATTGGCACATAACAAGTACTGCTCGGTCCTTAAGCTGTATTGCACCATATGACGG
ATGCCGGAATTGGCACATAACAAGTACTGCCTCGGTCCTTAAGCTGTATTGCACCATATGACGGATGCCGGAATTGGCACATAACAAGTAC
TGCCTCGGTCCTTAAGCTGTATTGCACCATATGACGGATGCCGGAATTGGCACATAACAACGGTCCTTAAGCTGTATTGCACCATATGACG
GATGCCGGAATTGGCACATAACAAGTACTGCCTCGGTCCTTAAGCTGTATTTCGGTCCTTAAGCTGTATTCCTTAACAACGGTCCTTAAGG
picture of Vincent Zoete

Computer-aided Molecular Engineering

Visit group webpage See group members
Vincent Zoete
University of Lausanne
Lausanne

The laboratory specializes in the development of computer-aided algorithms, programs and databases for protein engineering, drug design and structure-based immunoinformatics with applications in oncology, notably in immunotherapy of cancer. We also provide support in Molecular Modeling for the Molecular Tumor Board of the Lausanne University Hospital.

Domain(s) of application
Medicine and health
Domain of activity
Structural biology
Activity tags

More from the group

The SIB Remarkable Outputs are a shortlist of must-read or works created by SIB Members each year.
News

Discover the SIB Remarkable Outputs 2023

Staying abreast of the latest advances and bright ideas emerging in a field as...
a 3d image of a group of different colored proteins
News

Facilitating access and reuse of computer-predicted protein structures

ModelArchive, an open repository for sharing computationally determined protein...
Stock market investment graph on financial numbers abstract background.3d illustration
News

SIB catalyzes open research data practices in Switzerland

SIB Members are leading or involved in several projects which have been awarded...
Celestia logo
News

Collaborating with Cellestia Biotech to launch new drug discovery program

Cellestia Biotech , specialized in targeting Transcription Factors (TFs)...
four dices with the letter of news
News

Joining forces to develop new approaches to cancer immunotherapy

One of the Sinergia 2020 fellowships of the Swiss National Science Foundation...
an illustration of a meeting room with a group of people
News

Understanding precision medicine with PrecisionMed.ch

While precision medicine is already a reality in the field of cancer treatment...